RECOVERY Collaborative Group 2023, ' Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507 . https://doi.org/10.1016/S0140-6736(23)00510-X
Davies, B, Mowforth, O D, Yordanov, S, Alvarez-Berdugo, D, Bond, S, Nodale, M, Kareclas, P, Whitehead, L, Bishop, J, Chandran, S, Lamb, S, Bacon, M, Papadopoulos, M C, Starkey, M, Sadler, I, Smith, L, Kalsi-Ryan, S, Carpenter, A, Trivedi, R A, Wilby, M, Choi, D, Wilkinson, I B, Fehlings, M G, Hutchinson, P J & Kotter, M R N 2023, ' Targeting patient recovery priorities in degenerative cervical myelopathy : design and rationale for the RECEDE-Myelopathy trial-study protocol ', BMJ Open, vol. 13, no. 3, e061294, pp. e061294 . https://doi.org/10.1136/bmjopen-2022-061294
Mumford, A D & Gibbison, B J J 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 Dimitriadis, G K 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 RECOVERY Collaborative Group & Dark, P 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet . https://doi.org/10.1016/S0140-6736(22)01109-6
Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
RECOVERY Collaborative Group & Downey, D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Mumford, A D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Lancet (London, England) Group, RECOVERY C, Felton, T, Dark, P & Mathioudakis, A 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5
Shuwa, H A, Shaw, T N, Knight, S B, Wemyss, K, McClure, F A, Pearmain, L, Prise, I, Jagger, C, Morgan, D J, Khan, S, Brand, O, Mann, E R, Ustianowski, A, Bakerly, N D, Dark, P, Brightling, C E, Brij, S, Felton, T, Simpson, A, Grainger, J R, Hussell, T, Konkel, J E & Menon, M 2021, ' Alterations in T and B cell function persist in convalescent COVID-19 patients ', Med, vol. 2, no. 6, pp. 720-735.E4 . https://doi.org/10.1016/j.medj.2021.03.013 Shuwa, H A, Shaw, T, Knight, S, Wemyss, K, Mcclure, F, Pearmain, L, Prise, I, Jagger, C, Morgan, D, Khan, S, Brand, O, Mann, E, Ustianowski, A, Diar Bakerly, N, Dark, P, Brightling, C E, Brij, S, Felton, T, Simpson, A, Grainger, J, Hussell, T, Konkel, J & Menon, M 2021, ' Alterations in T and B cell function persist in convalescent COVID-19 patients ', Med, vol. 2, no. 6, pp. 720-+ . https://doi.org/10.1016/j.medj.2021.03.013 Med (New York, N.y.)
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5